Operation Coordinator2--He Fei at IQVIA

Hefei, China

IQVIA Logo
Not SpecifiedCompensation
InternshipExperience Level
Part TimeJob Type
UnknownVisa
Healthcare, Pharmaceuticals, Clinical ResearchIndustries

Requirements

  • Japanese N2 level or equivalent Japanese language ability
  • CET4 level or above in English
  • Bachelor's degree or higher (any major acceptable; biology or pharmacy preferred)
  • Ability to participate in a 3-month internship, with a minimum of 3-4 days of attendance per week and at least 14 days of attendance per month

Responsibilities

  • Assist the supervisor with collecting, statistical analysis, and documentation of adverse drug reactions
  • Assist the supervisor with conducting adverse drug reaction event reporting, periodic safety update reports, event investigations, evaluations, and handling
  • Maintain and preserve drug adverse reaction monitoring records

Skills

Japanese N2
English CET4
Statistical Analysis
Adverse Drug Reaction Reporting
Pharmacovigilance
Regulatory Reporting
Event Investigation
Data Documentation

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Durham, North CarolinaHeadquarters
1998Year Founded
$3,526MTotal Funding
POST_IPO_EQUITYCompany Stage
Cybersecurity, Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.
Proliferation of disparate technological solutions causes technology overload in clinical trials.
Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.
The company offers privacy-enhancing technologies to protect individual patient data.
IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.
AI-driven drug discovery accelerates identification of potential drug candidates.
Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI